Annual Revenue
$21.17 M
+$9.91 M+88.05%
December 31, 2021
Summary
- As of February 10, 2025, FSTX annual revenue is $21.17 million, with the most recent change of +$9.91 million (+88.05%) on December 31, 2021.
- During the last 3 years, FSTX annual revenue has fallen by -$7.15 million (-25.26%).
Performance
FSTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$1.13 M
NaN%
September 30, 2022
Summary
- As of February 10, 2025, FSTX quarterly revenue is $1.13 million
- Over the past year, FSTX quarterly revenue has increased by +$374.00 thousand (+49.80%).
Performance
FSTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
$21.18 M
NaN%
September 30, 2022
Summary
- As of February 10, 2025, FSTX TTM revenue is $21.18 million
- Over the past year, FSTX TTM revenue has increased by +$17.34 million (+452.73%).
Performance
FSTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
FSTX Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +88.0% | +49.8% | +452.7% |
3 y3 years | -25.3% | -17.0% | +1462.7% |
5 y5 years | -25.3% | -17.0% | +1462.7% |
FSTX Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | at low | -93.6% | at low | at high | -1.8% |
5 y | 5-year | -25.3% | -46.8% | -93.6% | -85.5% | at high | -93.6% |
alltime | all time | -25.3% | -46.8% | -93.6% | -85.5% | at high | -93.6% |
F-star Therapeutics Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2022 | - | $1.13 M(-55.9%) | $21.18 M(+1.8%) |
Mar 2022 | - | $2.55 M(-85.4%) | $20.80 M(-1.7%) |
Dec 2021 | $21.17 M(+88.1%) | $17.50 M(+2230.1%) | $21.17 M(+452.5%) |
Sep 2021 | - | $751.00 K(-74.3%) | $3.83 M(-70.1%) |
Mar 2021 | - | $2.92 M(+1689.6%) | $12.82 M(+13.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2020 | $11.26 M(-60.3%) | $163.00 K(-98.2%) | $11.26 M(+1.5%) |
Sep 2020 | - | $9.20 M(+1593.4%) | $11.09 M(+484.5%) |
Jun 2020 | - | $543.00 K(-59.9%) | $1.90 M(+40.1%) |
Mar 2020 | - | $1.35 M | $1.35 M |
Dec 2019 | $28.32 M | - | - |
FAQ
- What is F-star Therapeutics annual revenue?
- What is the all time high annual revenue for F-star Therapeutics?
- What is F-star Therapeutics annual revenue year-on-year change?
- What is F-star Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for F-star Therapeutics?
- What is F-star Therapeutics quarterly revenue year-on-year change?
- What is F-star Therapeutics TTM revenue?
- What is the all time high TTM revenue for F-star Therapeutics?
- What is F-star Therapeutics TTM revenue year-on-year change?
What is F-star Therapeutics annual revenue?
The current annual revenue of FSTX is $21.17 M
What is the all time high annual revenue for F-star Therapeutics?
F-star Therapeutics all-time high annual revenue is $28.32 M
What is F-star Therapeutics annual revenue year-on-year change?
Over the past year, FSTX annual revenue has changed by +$9.91 M (+88.05%)
What is F-star Therapeutics quarterly revenue?
The current quarterly revenue of FSTX is $1.13 M
What is the all time high quarterly revenue for F-star Therapeutics?
F-star Therapeutics all-time high quarterly revenue is $17.50 M
What is F-star Therapeutics quarterly revenue year-on-year change?
Over the past year, FSTX quarterly revenue has changed by +$374.00 K (+49.80%)
What is F-star Therapeutics TTM revenue?
The current TTM revenue of FSTX is $21.18 M
What is the all time high TTM revenue for F-star Therapeutics?
F-star Therapeutics all-time high TTM revenue is $21.18 M
What is F-star Therapeutics TTM revenue year-on-year change?
Over the past year, FSTX TTM revenue has changed by +$17.34 M (+452.73%)